FINWIRES · TerminalLIVE
FINWIRES

Wantai Biological Pharmacy Narrows Q1 Loss; Shares Fall 3%

By

-- Beijing Wantai Biological Pharmacy Enterprise (SHA:603392) posted first-quarter attributable net loss of 43 million yuan, compared with 53 million yuan the previous year.

Loss per share narrowed to 0.03 yuan from 0.04 yuan, according to a Tuesday filing with the Shanghai bourse.

Revenue rose 31% year over year to 523 million yuan from 401 million yuan.

Shares of the drug manufacturer were down 3% in recent trade.

Related Articles

Asia

Star Asia Investment Completes Redemption of Preferred Equity Securities

Star Asia Investment (TYO:3468) completed the redemption of all preferred equity securities it held in a real estate-backed structure, with proceeds expected to generate a gain, according to a Tuesday filing on the Tokyo Stock Exchange.The real estate investment trust said it redeemed the securities on April 28 and expects to record a gain of about 151 million yen for the fiscal period ending July 2026. It will also receive dividends related to the securities.The preferred equity securities, acquired in June 2023 for about 1.56 billion yen, were linked to a structure holding the HAKUSAN HOUSE property.

$TYO:3468
Asia

SMS Revises Stock Option to Offset Impairment Impact on Performance Targets

SMS Co (TYO:2175) will amend the exercise conditions for its paid-in stock options to exclude the impact of reduced amortization expenses following an impairment loss, according to a Tuesday filing on the Tokyo Stock Exchange.The changes apply to the company's 20th and 21st stock acquisition rights, which carry performance-based conditions tied to adjusted operating income for fiscal 2027 and fiscal 2028, respectively.SMS said it expects amortization expenses tied to intangible assets to decline by about 1.5 billion yen annually from fiscal 2027 after recognizing an impairment loss in its overseas business for the fiscal year ended March 2026.

$TYO:2175
Asia

Shenglong Mining's Attributable Profit Jumps 17% in 2025

Luoyang Shenglong Mining's (SHE:001257) attributable profit rose 17% to 883.9 million yuan in 2025 from 756.8 million yuan in 2024, according to a Tuesday filing with the Shenzhen bourse.Earnings per share at the molybdenum mining company increased 17% to 0.5453 yuan from 0.4669 yuan in the previous year.Operating revenue grew 22% year over year to 3.50 billion yuan from 2.86 billion yuan.

$SHE:001257